MAYNE PHARMA LTD has a total of 14 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are PHARMALYTE SOLUTIONS LLC, ACHELIOS THERAPEUTICS INC and MONTE VERDE S A.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | United Kingdom | 1 | |
#7 | Hong Kong | 1 | |
#8 | New Zealand | 1 | |
#9 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Liu Aikun Julie | 10 |
#2 | Whittaker Darryl Vanstone | 7 |
#3 | Ash Daniel David | 4 |
#4 | Spencer Allan Harvey | 4 |
#5 | Knill Andrew Malcolm | 3 |
#6 | Lin Song | 1 |
#7 | Kalidindi Raju | 1 |
#8 | Vanstone Whittaker Darryl | 1 |
#9 | Zhong Huijan | 1 |
#10 | Hooley Kellie Ann | 1 |
Publication | Filing date | Title |
---|---|---|
US2009118354A1 | Liquid Pharmaceutical Formulations of Docetaxel | |
WO2007112473A1 | Purification of a difluoronucleoside anomer using aqueous acid solution | |
GB0718274D0 | Acid containing oxaliplatin formulation | |
AU2004267877A1 | Acid containing oxaliplatin formulations | |
CN101703467A | Acid containing oxaliplatin formulations |